Search Results - "Porceddu, S"

Phase II study of single-agent panitumumab in patients with incurable cutaneous squamous cell carcinoma by Foote, M.C., McGrath, M., Guminski, A., Hughes, B.G.M., Meakin, J., Thomson, D., Zarate, D., Simpson, F., Porceddu, S.V.

“…Although advanced cutaneous squamous cell carcinoma (CSCC) is quite common, there are few prospective trials regarding its optimal management. This study…”
Get full text

Dental management of patients irradiated for head and neck cancer by Beech, N, Robinson, S, Porceddu, S, Batstone, M

“…Patients undergoing radiation therapy as either primary, adjuvant, combination therapy or palliative management of head and neck malignancies are prone to a…”
Get full text

Identification of an excellent prognosis subset of human papillomavirus-associated oropharyngeal cancer patients by quantification of intratumoral CD103+ immune cell abundance by Solomon, B., Young, R.J., Bressel, M., Cernelc, J., Savas, P., Liu, H., Urban, D., Thai, A., Cooper, C., Fua, T., Neeson, P., Loi, S., Porceddu, S.V., Rischin, D.

“…Accurate prognostic stratification of human papillomavirus-associated oropharyngeal cancers (HPV+OPSCC) is required to identify patients potentially suitable…”
Get full text

Prognostic stratification of HPV-associated oropharyngeal cancer based on CD103 + immune cell abundance in patients treated on TROG 12.01 and De-ESCALaTE randomized trials by Rischin, D, Mehanna, H, Young, R J, Bressel, M, Dunn, J, Corry, J, Soni, P, Fulton-Lieuw, T, Iqbal, G, Kenny, L, Porceddu, S, Wratten, C, Robinson, M, Solomon, B J

“…High CD103 intratumoral immune cell (ITIC) abundance is associated with better prognosis in unselected patients with human papilloma virus-associated…”
Get full text

Olfactory neuroblastoma: 14-year experience at an Australian tertiary centre and the role for longer-term surveillance by Schmidt, C, Potter, N, Porceddu, S, Panizza, B

“…Olfactory neuroblastoma is a rare sinonasal malignancy, with poorly defined treatment protocols. Management at a tertiary centre was retrospectively evaluated…”
Get more information

DID THE ANCIENT EGYPTIANS RECORD THE PERIOD OF THE ECLIPSING BINARY ALGOL—THE RAGING ONE? by Jetsu, L, Porceddu, S, Lyytinen, J, KAJATKARI, P, Lehtinen, J, Markkanen, T, Toivari-Viitala, J

“…The eclipses in binary stars give precise information of orbital period changes. Goodricke discovered the 2.867 day period in the eclipses of Algol in the year…”
Get full text

Pre-radiotherapy dental extractions and osteoradionecrosis by Beech, N, Porceddu, S, Batstone, M

Get full text

Pre-radiotherapy dental extractions and quality of life by Beech, N, Porceddu, S, Batstone, M

Get full text

Human papillomavirus modifies the prognostic significance of T stage and possibly N stage in tonsillar cancer by Hong, A.M., Martin, A., Armstrong, B.K., Lee, C.S., Jones, D., Chatfield, M.D., Zhang, M., Harnett, G., Clark, J., Elliott, M., Milross, C., Smee, R., Corry, J., Liu, C., Porceddu, S., Vaska, K., Veness, M., Morgan, G., Fogarty, G., Veivers, D., Rees, G., Rose, B.

“…Despite the association with more advanced nodal stage, patients with human papillomavirus (HPV) positive oropharyngeal cancers have better outcomes. We…”
Get full text

The Use of Predictive Modeling in Adaptive Radiation Therapy for Head and Neck Cancer by Brown, E, Owen, R, Harden, F, Mengersen, K, Oestreich, K, Houghton, W, Poulsen, M.G, Harris, S, Lin, C, Porceddu, S

Get full text

Randomized study of percutaneous endoscopic gastrostomy versus nasogastric tubes for enteral feeding in head and neck cancer patients treated with (chemo)radiation by Corry, J, Poon, W, McPhee, N, Milner, AD, Cruickshank, D, Porceddu, SV, Rischin, D, Peters, LJ

“…Summary Percutaneous endoscopic gastrostomy (PEG) tubes have largely replaced nasogastric tubes (NGT) for nutritional support of patients with head and neck…”
Get full text

Influence of Domiciliary Humidification on Symptom Burden and Feeding Tube Use Up to 2 Years Postradiation Therapy for Head and Neck Cancer: Trans-Tasman Radiation Oncology Group (TROG) 07.03 RadioHUM Randomized Phase 2 Trial Secondary Analysis by Macann, A.M.J, Fua, T, Milross, C.G, Porceddu, S, Penniment, M.G, Wratten, C, Krawitz, H, Poulsen, M.G, Tang, C.I, Morton, R.P, Thomson, V, Bell, M.L, King, M.T, Fraser-Browne, C.L, Hockey, H.U.P

Get full text

Outcomes Following Primary Chemoradiation Therapy for N3 Head and Neck Squamous Cell Carcinoma With PET-Directed Neck Management Policy: A Diminishing Role for Planned Neck Dissection by Porceddu, S, Adams, G, Pryor, D, Panizza, B, Foote, M, Burmeister, B

Get full text

Improvement of delineation quality of organs at risk in head and neck using the consensus guidelines by Steenbakkers, R, Brouwer, C, Bourhis, J, Budach, W, Grau, C, Grégoire, V, Van Herk, M, Lee, A, Maingon, P, Nutting, C, O’Sullivan, B, Porceddu, S, Rosenthal, D, Sijtsema, N, Langendijk, J

Get full text

T-category Remains an Important Prognostic Factor for Oropharyngeal Carcinoma in the Era of Human Papillomavirus by Mackenzie, P, Pryor, D, Burmeister, E, Foote, M, Panizza, B, Burmeister, B, Porceddu, S

“…Abstract Aims To determine prognostic factors for locoregional relapse (LRR), distant relapse and all-cause death in a contemporary cohort of locoregionally…”
Get full text

Single Agent Panitumumab in Patients With Incurable Cutaneous Squamous Cell Carcinoma: A Single-Center Phase 2 Study by Porceddu, S, Foote, M, McGrath, M, Guminski, A, Hughes, B, Meakin, J, Thomson, D, Simpson, F

Get full text

An International Survey of Definitive SABR for Extracranial Limited Metastases by Lewis, S.L, Porceddu, S, Hoskin, P, Chmura, S, Moghanaki, D, Lo, S, Palma, D, Nakamura, N, Salama, J

Get full text

Distinct patterns of stomatitis with concurrent cetuximab and radiotherapy for head and neck squamous cell carcinoma by Pryor, D.I, Burmeister, E, Burmeister, B.H, Poulsen, M.G, Porceddu, S.V

“…Summary To describe the distinct patterns of severe anterior stomatitis seen with concurrent cetuximab and radiotherapy (RT) compared to chemoRT or altered…”
Get full text

Domiciliary Humidification Reduces Symptom Burden and Hospital Admissions Associated With Mucositis During Radiation Therapy for Head-and-Neck Cancer: Trans-Tasman Radiation Oncology Group (TROG) 07.03 RadioHUM Randomized Phase 3 Trial Results by Macann, A, Porceddu, S, Milross, C, Fua, T, Penniment, M, King, M, Bell, M, Fraser-Browne, C, Thomson, V, Hockey, H

Get full text

OC-0143: Managing mucositis with humidification during radiotherapy for head and neck cancer: TROG 07.03 RadioHUM results by Macann, A, Porceddu, S, Milross, C, Penniment, M, Fua, T, Fraser-Browne, C, Thomson, V, Hockey, H, Bell, M, King, M

Get full text